Literature DB >> 11319067

Comparison and cost analysis of different treatment strategies in achalasia.

J E Richter1.   

Abstract

Currently there are three acceptable long-term treatments of achalasia: pneumatic dilatation, laparoscopic Heller myotomy, and botulinum toxin injection. Primarily retrospective studies suggest equal efficacy of pneumatic dilatation and surgical myotomy, especially in centers with expertise in both treatments. Randomized prospective studies find pneumatic dilatation superior to botulinum toxin because of the need for serial frequent treatments with the latter therapy. All cost analysis studies support the superiority of pneumatic dilatation over the two other treatments.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11319067

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  11 in total

1.  Treatment of esophageal achalasia with Heller myotomy: retrospective evaluation of patient satisfaction and disease-specific quality of life.

Authors:  Yen Dang; Dale Mercer
Journal:  Can J Surg       Date:  2006-08       Impact factor: 2.089

Review 2.  Achalasia of the cardia: dilatation or division? The case for balloon dilatation.

Authors:  P J Lamb; S M Griffin
Journal:  Ann R Coll Surg Engl       Date:  2006-01       Impact factor: 1.891

3.  Robot-assisted laparoscopic cardiomyotomy.

Authors:  Heinz F Wykypiel; Johannes Bodner; Florian Augustin; Oliver Renz; Elisabeth Hoeller; Thomas Schmid
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

4.  Long-term results of pneumatic dilation for achalasia: a 15 years' experience.

Authors:  Panagiotis Katsinelos; Jannis Kountouras; George Paroutoglou; Athanasios Beltsis; Christos Zavos; Basilios Papaziogas; Kostas Mimidis
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

5.  Pneumatic dilation for achalasia: late results of a prospective follow up investigation.

Authors:  V F Eckardt; I Gockel; G Bernhard
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

6.  Heller myotomy for failed pneumatic dilation in achalasia: how effective is it?

Authors:  Ines Gockel; Th Junginger; Gudrun Bernhard; Volker F Eckardt
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

7.  For patients with primary achalasia the clinical success of pneumatic balloon dilatation can be predicted from the residual fraction of radionuclide during esophageal transit scintigraphy.

Authors:  Han Ho Jeon; Young Hoon Youn; Kwangwon Rhee; Jie-Hyun Kim; Hyojin Park; Jeffrey L Conklin
Journal:  Dig Dis Sci       Date:  2013-10-29       Impact factor: 3.199

8.  Pneumatic balloon dilation therapy is as effective as esophagomyotomy for achalasia.

Authors:  Mohammad Hassan Emami; Mostafa Raisi; Jaleh Amini; Abbas Tabatabai; Mehran Haghighi; Hamid Tavakoli; Mozafar Hashemi; Mehdi Fude; Ziba Farajzadegan; Vahid Goharian
Journal:  Dysphagia       Date:  2008-02-06       Impact factor: 3.438

9.  A review of factors predicting outcome of pneumatic dilation in patients with achalasia cardia.

Authors:  Uday C Ghoshal; Murali Rangan
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

10.  The early efficacy of Heller myotomy in the treatment of Iranian patients with achalasia.

Authors:  Saeed Abdi; Mojgan Forotan; Abdolrahim Nikzamir; Saeedeh Zomorody; Somayeh Jahani-Sherafat
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.